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greater reduction in tinnitus severity than RT, with a mean 
difference of 6.3 (95% CI 1.3–11.4,  p = 0.016). Effects persist-
ed 6 months later, with a mean difference of 7.2 (95% CI 2.1–
2.3,  p = 0.006) and a standardized effect size of 0.56 (95% CI 
0.16–0.96). Treatment was effective regardless of initial tin-
nitus severity, duration, or hearing loss.  Conclusions: MBCT 
is effective in reducing tinnitus severity in chronic tinnitus 
patients compared to intensive RT. It also reduces psycho-
logical distress and disability. Future studies should explore 
the generalizability of this approach and how outcome re-
lates to different aspects of the intervention. 
 © 2017 S. Karger AG, Basel 
 Introduction 
 Persistent tinnitus is experienced by 10–15% of the 
population  [1] . Approximately half report at least moder-
ate annoyance and 1–2% report significant distress and 
disability. Insomnia, anxiety, depression, hearing prob-
lems, and cognitive processing difficulties are common 
 [1] .
 There is rarely a medical or surgical solution to tinni-
tus and the clinical challenge is to relieve associated dis-
tress. Tinnitus is affected by cognitive, behavioural, and 
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 Abstract 
 Background: Tinnitus is experienced by up to 15% of the 
population and can lead to significant disability and distress. 
There is rarely a medical or surgical target and psychologi-
cal therapies are recommended. We investigated whether 
mindfulness-based cognitive therapy (MBCT) could offer an 
effective new therapy for tinnitus.  Methods: This single-site 
randomized controlled trial compared MBCT to intensive re-
laxation training (RT) for chronic, distressing tinnitus in 
adults. Both treatments involved 8 weekly, 120-min sessions 
focused on either relaxation (RT) or mindfulness meditation 
(MBCT). Assessments were completed at baseline and at 
treatment commencement 8 weeks later. The primary out-
comes were tinnitus severity (Tinnitus Questionnaire) and 
psychological distress (Clinical Outcomes in Routine Evalua-
tion – Non-Risk, CORE-NR), 16 weeks after baseline. The anal-
ysis utilized a modified intention-to-treat approach.  Results: 
A total of 75 patients were randomly allocated to MBCT ( n = 
39) or RT ( n = 36). Both groups showed significant reductions 
in tinnitus severity and loudness, psychological distress, anx-
iety, depression, and disability. MBCT led to a significantly 
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neuronal factors. The natural history of tinnitus involves 
habituation; simply waiting for treatment can reduce dis-
tress  [2] . Habituation is facilitated by reducing stress 
arousal and minimizing the emotional significance of tin-
nitus. The strongest evidence for treatment is for cogni-
tive behavioural therapy (CBT)  [3, 4] , and a stepped-care 
approach combining CBT and tinnitus retraining therapy 
is supported  [5] . 
 Recent developments in CBT incorporate mindfulness 
and “acceptance-based” approaches. Mindfulness in-
volves bringing a certain quality of attention to present 
moment experience  [6] . Standard programmes include 
mindfulness-based stress reduction (MBSR) or mindful-
ness-based cognitive therapy (MBCT); the latter more 
closely aligns with psychological theory. MBCT reduces 
relapse rates in recurrent depression  [7] and mindfulness 
therapies are advocated in a range of medical settings  [6] , 
including chronic pain  [8] , a condition that has similari-
ties to tinnitus  [9] .
 Meta-analyses of mindfulness-based therapy across 
conditions report effects equal to cognitive and behav-
ioural therapies  [10] . In the treatment of long-term med-
ical conditions, mindfulness-based therapies (excluding 
MBCT) have some evidence  [11] . Applications of mind-
fulness to tinnitus are in their infancy, and as yet there 
have been just 7 relevant studies published, of which only 
2 are randomized controlled trials  [12, 13] . These trials 
have indicated potential benefits of mindfulness, but both 
have reported on small sample sizes only, and neither ad-
hered to the standardized (and thus replicable) MBCT or 
MBSR protocols advised in the psychological and medical 
literature. 
 Mechanisms of mindfulness may include the self-reg-
ulation of attention towards the present moment, charac-
terized by curiosity, openness, and acceptance  [14, 15] . By 
fostering a non-judgmental focus in the present moment, 
mindfulness may reduce negative cognitions which are 
known to be associated with anxiety, depression, and tin-
nitus severity  [16] . MBCT may improve cognitive and 
metacognitive awareness (awareness of the link between 
negative thinking and negative emotional states). This 
could allow individuals to establish a different relation-
ship with negative experiences, whereby they are less 
emotionally destructive  [15] . Distressed tinnitus patients 
often attempt to avoid or escape environments which 
they fear may increase their tinnitus or awareness of tin-
nitus (i.e., particularly noisy or quiet places, or by keeping 
busy to distract from tinnitus). Such behaviours are as-
sociated with anxiety and tinnitus severity and related 
distress  [17, 18] . MBCT targets avoidance by encouraging 
exposure to and acceptance of tinnitus. Tinnitus accep-
tance mediates between initial tinnitus distress and later 
depression, quality of life, and distress  [19] . By reducing 
avoidance and enhancing acceptance, mindfulness is 
likely to lead to significant benefits in tinnitus patients.
 There is growing interest in mindfulness in audiology 
 [20] . This growth is taking place in the context of a na-
scent evidence base, indicating an urgent need for rigor-
ous controlled trials. We developed an intervention based 
on a standard 8-week MBCT protocol, adapted for tinni-
tus, an important issue in a field where mindfulness-
based interventions vary widely. A pre-post study found 
that this was effective in reducing tinnitus severity, im-
proving psychological well-being, and acceptance in 
chronic tinnitus patients [unpubl. data].
 A randomized controlled trial was developed to estab-
lish whether MBCT is an effective treatment for tinnitus, 
and whether it is more effective than an existing treat-
ment delivered at equivalent intensity (relaxation train-
ing, RT). MBCT was therefore compared to both a pre-
treatment waiting period and to an active control condi-
tion (RT). We hypothesized that MBCT would lead to a 
greater reduction in tinnitus severity, psychological dis-
tress, functional disability, avoidance, and negative cog-
nitions and a greater increase in tinnitus acceptance than 
RT by the end of treatment, and in comparison to a wait-
ing period. Psychological treatment does not directly tar-
get tinnitus volume, so we hypothesized that this would 
remain unchanged. 
 Methods 
 Study Design and Participants 
 This was a 2-group randomized controlled trial, conducted at 
the Royal National Throat, Nose and Ear Hospital, London, UK. 
Adult patients were recruited between January 2013 and March 
2015. Consecutive referrals to the clinical psychology department 
were screened for eligibility. Inclusion criteria were (1) aged 18 
years or over; (2) reported tinnitus of more than 6 months’ dura-
tion; (3) reported clinical levels of psychological distress (Clinical 
Outcomes in Routine Evaluation – Non-Risk, CORE-NR score 
>10); (4) completed medical investigations for tinnitus; and (5) 
sufficient command of English and hearing levels allowing par-
ticipation in group discussions. Exclusion criteria were (1) current, 
comorbid, severe physical or mental illness; (2) current risk factors 
of active suicidal ideation or self-harm; (3) current substance de-
pendence.
 Ethical Considerations 
 To manage the ethical implications of random allocation to dif-
ferent treatment conditions, all patients provided full, informed 
consent. Those opting out of the study were offered standard care 
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no patient was denied help. After completing the study, all par-
ticipants could opt to choose the alternative intervention. There 
were no changes to the trial design following its commencement. 
 Randomization and Masking 
 Randomization was done in cohort groups of 15–19 partici-
pants, to ensure a group size of 6–10. Anonymized details were 
sent to an independent researcher at the Ear Institute (UCL, Lon-
don, UK). They were randomly allocated to RT or MBCT by com-
puter. Randomization was stratified by age and gender, conducted 
independently for each cohort group to ensure later allocation se-
quence was not affected. Allocations were sent to the trial clinical 
psychologists (L.M. and E.M.M.) who informed participants 4 
weeks prior to commencing treatment. It was not possible to mask 
the participants or clinicians to allocation, although participants 
were masked to the content of the alternative treatment. Indepen-
dent statisticians analysing the results were masked to group for 
the initial analyses. The work was conducted at the Royal Nation-
al Throat, Nose and Ear Hospital, London, UK. Ethical approval 
was given by the UK NHS research committee and the trial was 
registered with Clinical Trials.gov (NCT02059447).
 Procedures 
 Eligibility assessment involved a 1-hour interview with a clini-
cal psychologist and completion of a screening questionnaire: 
Clinical Outcomes in Routine Evaluation – Outcome Measure 
(CORE-OM). Following consent participants completed a battery 
of outcome questionnaires at baseline, 8 weeks prior to treatment. 
An 8-week waiting period without intervention followed. Out-
come questionnaires were completed at 4 additional time points 
after baseline: 8 weeks (pre-treatment), 16 weeks (post-treatment), 
20 weeks (1-month follow-up), and 40 weeks (6-month follow-
up). Follow-up was completed by December 2015.  
 Both interventions consisted of eight 120-min group sessions, 
delivered weekly over 8 consecutive weeks. Groups were run on 
the same day with counterbalancing of morning/afternoon deliv-
ery. Two clinical psychologists were involved in the study; both 
had qualifications in CBT, expertise in RT, and teacher training in 
mindfulness-based approaches from Bangor University. Treat-
ment fidelity and procedural adherence was assessed through 
weekly briefing sessions between the clinicians and regular super-
vision with accredited mindfulness supervisors.
 Both MBCT and RT were structured programmes, delivered in 
line with manuals (details in Supplementary Text; for all online 
suppl. material, see www.karger.com/doi/10.1159/000478267). 
MBCT was based on the protocol for depression  [14] , with tinnitus-
related modifications that included a greater emphasis on sound 
meditation and education around the cognitive model of tinnitus 
 [21] , and the importance of attentional processes in tinnitus. RT 
was based on standardized interventions for relaxation  [22] , adapt-
ed to create an 8-week course for comparability to MBCT. Both 
groups had a similar framework, involving formal experiential ex-
ercises (either relaxation or meditation), discussion, and psycho-
education within the group. Psycho-education in RT focused on 
the physiology of stress and tinnitus, and in MBCT it focused on 
cognitive theory. Both groups were asked to complete equivalent 
amounts of daily formal practice (supported by audio guides) and 
to begin to apply their practice of either mindfulness or relaxation 
to daily life. In line with advised protocols, MBCT participants re-
ceived supporting literature but RT participants did not. 
 Outcomes 
 The primary outcomes were change from pre- to post-treat-
ment in tinnitus severity and psychological distress. The Tinnitus 
Questionnaire (TQ) assesses self-reported tinnitus severity with 41 
items on a 3-point scale. The scale has high test-retest reliability 
and internal consistency  [23] . Reliable change was calculated as 11 
points [unpubl. data]. CORE-OM  [24] is a pan-diagnostic measure 
of psychological distress with items scored on a 5-point scale, and 
the mean of all scores multiplied by 10. It has good reliability and 
validity. The most useful scoring method for assessing clinical 
change uses the 28 non-risk items (CORE-NR)  [25] . A mean score 
over 10 is clinically important, and reliable change is indicated by 
a change in score >5.
 Secondary outcomes included additional time points: effect of 
waiting period (change from baseline to pre-treatment) and long-
term effects (change from pre-treatment to 1-month and 6-month 
follow-ups), and the following measures:
 Perceived Tinnitus Loudness was measured with a 10-cm Vi-
sual Analogue Scale (VAS), a standard measure for subjective tin-
nitus loudness  [3] .
 The Tinnitus Functional Index (TFI)  [26] , has limited reliabil-
ity and validity in research samples  [27] , but was included follow-
ing a call from the tinnitus community to develop a consensual 
measure of tinnitus impact. It has 8 separate subscales and the to-
tal score can be used. 
 The Hospital Anxiety and Depression Scale (HADS)  [28] mea-
sures anxiety and depression. Fourteen items are scored from 0 to 
3. The scale has good psychometric properties that are maintained 
in tinnitus populations  [29] .
 The Tinnitus Catastrophizing Scale (TCS)  [16] assesses 
thoughts and feelings about tinnitus using a 13-item scale. Internal 
consistency is good, and convergent validity with the TQ is high 
( r = 0.74)  [16] . 
 The Tinnitus Fear Avoidance Scale (T-FAS) measured tinni-
tus-related fearful cognitions and behaviours around tinnitus. In-
ternal consistency is good  [17] . 
 The Tinnitus Acceptance Questionnaire (TAQ)  [19] is a 12-
item questionnaire assessing acceptance versus experiential avoid-
ance of tinnitus. The total score has good test-retest reliability and 
the subscales (“tinnitus willingness” and “activity engagement”) 
both have good internal consistency (α = 0.70 and α = 0.91).
 The Mindful Attention Awareness Scale (MAAS)  [30] mea-
sures dispositional mindfulness in daily life with 15 items on a 
6-point scale. In clinical populations reliability levels are high 
(>0.8)  [30] .
 The Work and Social Adjustment Scale (WSAS)  [31] is a wide-
ly used measure of impaired functioning. Five items are rated on a 
9-point scale, and total scores over 10 suggest significant function-
al impairment. Internal consistency ranges from 0.7 to 0.94 and 
test-retest correlation is good (0.73). 
 Demographic information was collected at assessment. Re-
cords were taken for number of sessions attended and minutes of 
practice per week to assess treatment adherence. Treatment satis-
faction was assessed using two 11-point Likert scales assessing per-
ceived “usefulness” and “relevance” of treatment 16 weeks after 
baseline. Potential adverse events, identified as significant deterio-
ration in mood or tinnitus severity, were recorded by the trial ther-











   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
























253 tinnitus patients referred and screened for eligibility
175 excluded:
52 scored <10 on CORE-OM
48 reported significant comorbidities
27 declined treatment after assessment
20 declined/did not attend assessment
18 transferred to individual treatment 
 5 declined group MBCT, 5 due to 
 severe hearing loss, 8 requested 
 individual therapy
5 declined randomization
5 were inappropriate referrals78 consented to take part
75 completed baseline measures and were 
randomly allocated to treatment within 4 weeks
3 chose not to participate and did not 
provide baseline data
36 in the relaxation training group 
completed pre-treatment measures
39 in the mindfulness-based cognitive therapy 
group completed pre-treatment measures
8 in cohort 1
6 in cohort 2
5 in cohort 3
9 in cohort 4
8 in cohort 5
6 in cohort 1
7 in cohort 2
9 in cohort 3
8 in cohort 4
9 in cohort 5
4 did not complete treatment
2 dropped out after session 2
(1 illness, 1 could not be contacted
2 chose not to participate
2 did not complete treatment
1 did not attend after session 2
1 chose not to participate
1 did not attend after session 8:
post-treatment measures not 
completed
3 could not be contacted 
at 6 months
1 could not be contacted
at 1 month
4 could not be contacted 
at 6 months
32 completed measures 
at post-treatment
36 completed measures 
at post-treatment
37 in contact 
at 1-month follow-up








 Fig. 1. CONSORT diagram: profile of enrolment and flow through the randomized controlled trial of mindful-
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 Statistical Analyses 
 A pilot study [unpubl. data] suggested that the standardized ef-
fect size corresponding to a reliable reduction in TQ is 11 points 
(standardized effect size 0.8; SD 12 points). A sample size of 74 was 
sufficient to give 80% power, allowing for 20% loss to follow-up, 
an inter-class correlation coefficient of 0.07 to account for cluster-
ing within groups, with an average of 7 participants per group, and 
a baseline to outcome correlation of 0.4.
 The statistical analysis plan was agreed upon before completion 
of data collection. We used a modified intention-to-treat ap-
proach; all patients allocated to treatment were included. Drop-out 
rates were small and similar between groups. Analyses were con-
ducted under the assumption that missing data were missing at 
random. Missing data points were systematically inputted based 
on recommendations for each questionnaire manual, whereby the 
mean of an individual scale was used to replace a missing data 
point only if no more than 20% of that individual scale was miss-
ing. In the rare cases where more than 20% of a scale was missing 
then missing data points were imputed as the last observation car-
ried forward (see online suppl. Table 1). To check the dependence 
of our conclusions on the intention-to-treat assumption, primary 
analyses were repeated for completers only. None of the results 
changed materially when only complete cases were analysed.
 Linear mixed models were used for all analyses accounting for 
repeated measurements. A random effect for participant was in-
cluded, and for each outcome, age, gender, duration of tinnitus, 
and presence of hearing loss were included as covariates. Differ-
ence between treatments is reported as a mean difference, adjusted 
for pre-treatment score in each group. Owing to the cohort struc-
ture of the trial, a sensitivity analysis was performed with an ad-
ditional random effect term included for treatment cohort. This 
increased the Akaike information criterion, without changing the 
outcomes, so analysis proceeded without a random effect for co-
hort. 
 All analyses were carried out in RStudio, using the lme4 pack-
age (v1.1-10) for linear mixed modelling. Effect sizes are reported 
as standardized mean differences (using baseline standard devia-
tion of scale). All planned analyses were parametric unless there 
was clear evidence of deviation from a normal distribution. Differ-
ences between groups at baseline were assessed using  t tests or the 
Mann-Whitney U test, chosen appropriately according to the dis-
tribution of the data. The Fisher exact test was used for analysis of 
categorical variables and differences in reliable change.
 Role of the Funding Source 
 The study sponsor did not play a role in the study design, data 
collection, analysis, interpretation, or write-up. L.M. and E.M.M. 
had full access to data and were responsible for final submission. 
R.S. had access to anonymized baseline information for random-
ization. R.S. and C.A.H. had access to anonymized data for anal-
yses. 
 Results 
 Between January 2013 and March 2015, 253 partici-
pants were screened for eligibility. A total of 175 were ex-
cluded (52 reported levels of psychological distress below 
eligibility criteria, 48 reported significant comorbidities, 
52 declined participation, 18 required individual therapy, 
and 5 were inappropriate referrals). Consent was given by 
78 although 3 then chose not to participate. Thus, 75 par-
ticipants were randomly allocated to treatment (36 to RT, 
39 to MBCT). Attrition from therapy was low (8%) and 
not significantly different between groups (odds ratio 
2.29, 95% CI 0.30–26.9); 4 withdrew from RT, and 2 from 
MBCT.  Figure 1 shows the trial profile.
 Table 1.  Demographic characteristics
Overall RT MBCT
Agea, years 50 (16) 53 (14) 47 (17)
Female sex 34 (45) 16 (44) 18 (46)
Time since tinnitus onset, 
monthsa 56 (104) 34 (72) 96 (108)
Education
No qualifications 3 (4) 1 (3) 2 (5)
School level 26 (35) 14 (39) 12 (31)
Higher education 40 (53) 17 (47) 23 (59)
Not given 6 (8) 4 (11) 2 (5)
Ethnic origin
White 60 (80) 27 (74) 33 (85)
Black 5 (7) 4 (11) 1 (3)
Other 10 (13) 5 (15) 5 (13)
Hearing loss
No 27 (36) 17 (47) 10 (26)
Yes 48 (64) 19 (53) 29 (74)
Hearing loss aided?
No 29 (39) 12 (33) 17 (44)
Yes 19 (25) 7 (19) 12 (31)
Not applicable 27 (36) 17 (47) 10 (26)
Other audiovestibular 
conditions
No 66 (88) 31 (86) 35 (90)
Yes 9 (12) 5 (14) 4 (10)
Other health conditions
No 22 (29) 8 (22) 14 (36)
Yes 53 (71) 28 (78) 25 (64)
Previous tinnitus 
treatments
No 40 (53) 20 (54) 20 (51)
Yes 35 (47) 16 (44) 19 (49)
Completed trial 
treatment
No 6 (8) 4 (11) 2 (5)
Yes 69 (92) 32 (89) 37 (95)
Sessions attendedb 6.9 (1.9) 6.6 (2.2) 7.1 (1.7)
“Usefulness”b 8.25 (1.55) 7.89 (1.55) 8.56 (1.50)
“Relevance”b 8.36 (1.46) 8.07 (1.71) 8.60 (1.19)
 Values are n (%) unless otherwise indicated. RT, relaxation 
therapy; MBCT, mindfulness-based cognitive therapy. a Values are 











   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
























 Baseline clinical characteristics and demographics were 
equivalent between groups ( Table 1 ), excepting median tin-
nitus duration, which was greater in the MBCT group ( p = 
0.04). Tinnitus was problematic overall (mean TQ score of 
50) and chronic (median duration 56 months). Psycholog-
ical distress was high (mean CORE-NR score of 19.1). Thir-
ty-five (47%) participants had previously tried treatments 
for tinnitus. The complexity of the client group was reflect-
ed by 48 (64%) reporting hearing loss, 9 (12%) reporting 
other audiovestibular conditions, and 53 (71%) reporting 
other health problems. Binary logistic regression found that 
no baseline characteristics were predictive of drop-out. 
 Effects on Tinnitus Severity  
 Both groups showed a significant reduction in tinnitus 
severity (TQ) pre- to post-treatment, but this was signifi-
cantly greater in MBCT (mean = 31.4, SD = 16.1), with 
the adjusted mean score in the MBCT group 6.3 points 
(95% CI 1.3–11.4,  p = 0.016) lower than in RT (mean = 
38.2, SD = 14.3) and a standardized effect size of 0.49 
(95% CI 0.09–0.89) ( Table 2 ). At the 1-month follow-up, 
the mean score in MBCT was essentially unchanged, and 
had declined by 2 points in RT; the adjusted mean differ-
ence was 4.8 points (95% CI –0.3 to 10,  p = 0.065) lower 
in the MBCT group, and this did not quite reach signifi-
cance. By the 6-month follow-up, the adjusted mean 
score in MBCT (mean = 23, SD –18.1) was 7.2 points 
(95% CI 2.1–12.3,  p = 0.006) lower than RT (mean = 35.6, 
SD = 16.8), with a standardized effect size of 0.56 (95% CI 
0.16–0.96) (see online suppl. Fig. 1a). 
 Clinically significant, reliable change required a reduc-
tion of at least 11 points on the TQ. Post-treatment, reli-
able change was observed in 59% of participants in the 
MBCT group and 44% in the RT group. The number 
needed to treat (NNT) was 6.9. Considering only reliable 
change, the difference between treatments was not sig-
nificant (odds ratio 1.8, 95% CI 0.72–4.49). At the 6-month 
follow-up, reliable change was observed in 62% of the 
MBCT and in 53% of the RT group (odds ratio 1.43, 95% 
CI 0.57–3.59); the NNT was 11.4.
 Effects on Psychological Distress 
 Both groups showed a significant reduction in psycho-
logical distress (CORE-NR) pre- to post-treatment. Post-
treatment, in MBCT (mean = 12.3, SD = 6.2), the mean 
decrease was 4.3 points (95% CI 2.5–6.1), and in RT 
(mean = 14.1, SD = 7.4), the mean decrease was 3.6 points 
(95% CI 2.1–5.0). There was no significant difference be-
tween the groups’ post-treatment scores: adjusted mean 
difference –0.7 points (95% CI –3.2 to 1.7,  p = 0.5). This 
pattern was sustained over time, and by 6 months, the 
mean reduction in MBCT (mean = 12, SD = 5.8) was 4.6 
points (95% CI 2.7–6.6), and in RT (mean = 14.3, SD = 8), 
the mean reduction was 3.3 points (95% CI 1.5–5.2). The 
adjusted mean difference between the groups was –1.3 
points (95% CI –3.8 to 1.2,  p = 0.2) (online suppl. Fig. 1b). 
 A reduction of >5 indicates reliable change on the 
CORE (item 23). At post-treatment, this was observed in 
49% of participants in the MBCT group and 28% in the 
RT group. The NNT was 4.8, and the odds ratio was 2.47 







p Effect size 
(95% CI)
TQ
Baseline 51 (12.8) 49.5 (13)
Pre-treatment 48.1 (14.1) 47.7 (13.8) –1 (–6.2 to 4.1) 0.696 –0.08 (–0.48 to 0.32)
Post-treatment 38.2 (14.3) 31.4 (16.1) –6.3 (–11.5 to –1.2) 0.016 –0.49 (–0.89 to –0.09)
1-month follow-up 36.2 (15.9) 30.9 (16.8) –4.8 (–10 to 0.3) 0.065 –0.38 (–0.78 to 0.02)
6-month follow-up 35.6 (16.8) 28 (18.1) –7.2 (–12.3 to –2.1) 0.006 –0.56 (–0.96 to –0.16)
CORE-NR
Baseline 20.2 (5.5) 18.1 (5)
Pre-treatment 17.6 (7) 16.6 (5.7) –1.1 (–3.6 to 1.3) 0.371 –0.21 (–0.67 to 0.25)
Post-treatment 14.1 (7.4) 12.3 (6.2) –0.7 (–3.2 to 1.7) 0.555 –0.14 (–0.6 to 0.32)
1-month follow-up 14.2 (7.8) 13 (6.2) –0.2 (–2.6 to 2.3) 0.887 –0.03 (–0.5 to 0.43)
6-month follow-up 14.3 (8) 12 (5.8) –1.3 (–3.8 to 1.2) 0.303 –0.24 (–0.71 to 0.22)
RT, relaxation therapy; MBCT, mindfulness-based cognitive therapy; TQ, Tinnitus Questionnaire; CORE-NR, Clinical Outcomes in 
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(95% CI 0.94–6.47). At the 6-month follow-up, the pro-
portion of participants experiencing reliable change in 
the MBCT and RT groups was 49 and 31%, respectively. 
This gives an NNT of 5.5 and an odds ratio of 2.16 (95% 
CI 0.84–5.57), which is not significant.
 Effects on Secondary Outcomes 
 Table 3 shows the secondary outcomes over time. The 
mean subjective tinnitus loudness (VAS) was significantly 
lower after treatment in both groups. Post-treatment 
scores for MBCT (mean = 56.6, SD = 25.2) represented a 
mean decrease of 14 points (95% CI 8.1–19.9) and in RT 
(mean = 59.2, SD = 22.5) a decrease of 12 points (95% 
CI 5.7–18.7). There were no significant differences be-
tween groups. At 6 months, a trend suggested that MBCT 
(mean = 55.1, SD = 29.9), led to a greater reduction in tin-
nitus loudness than RT (mean = 65.4, SD = 24.3): adjusted 
mean difference, 9.6 points (95% CI –19.7 to 0.5,  p = 
0.063). Variability in responses suggests that this may be 
an unreliable indicator of difference. The impact of tinni-
tus (TFI) was significantly lower after treatment in both 
groups but not significantly different ( p = 0.2), with a 
mean decrease of 18.4 in MBCT (mean = 42.2, SD = 19.2) 
and 13.6 in RT (mean = 49.2, SD = 19). By 6 months, the 
mean TFI score was unchanged in RT (mean = 49, SD = 
21.1) but had decreased in MBCT (mean = 37.2, SD = 
24.1), and this difference became significant ( p = 0.01).
 There were significant changes in measures of cogni-
tion, behaviour, and acceptance related to tinnitus. Both 
groups showed a significant reduction in tinnitus cata-
strophizing (TCS). Post-treatment this was significantly 
greater in MBCT (mean = 16.5, SD = 11.5) compared to 
RT (mean = 23.7, SD = 13.3): adjusted mean difference 
4.6 (95% CI 0.50–8.6,  p = 0.029). At 1 month, the mean 
score decreased slightly in the RT group, but in MBCT 
was essentially unchanged; at this point the groups were 
not significantly different ( p = 0.123). However, by 6 
months, the TCS scores were again significantly lower 
in MBCT (mean = 15.1, SD = 12.4) compared to RT 
(mean = 22.3, SD = 13.3): adjusted mean difference of 4.6 
points. The same pattern was seen in reported avoidance 
behaviours (T-FAS), with both groups reporting signifi-
cantly reduced avoidance behaviour post-treatment. This 
decrease was significantly greater in MBCT (mean = 38.4, 
SD = 13.3) compared to RT (mean = 45, SD = 13.5): ad-
justed mean difference 5.2 points (95% CI 0.7–9.7). At 1 
month, the groups were not different, but by 6 months, 
T-FAS scores were significantly lower in MBCT (mean = 
37.1, SD = 13.2) compared to RT (mean = 43, SD = 14.9): 
adjusted mean difference 4.5 points. Both groups showed 
a significant increase in tinnitus acceptance (TAQ) post-
treatment, but this was significantly greater in MBCT 
(mean = 42.8, SD = 12.4) compared to RT (mean = 36.8, 
SD = 9.8): adjusted mean difference 4.7 points (95% CI 
0.9–8.5,  p = 0.015). At 1 month, the mean score decreased 
slightly in the RT group, but was essentially unchanged in 
MBCT, so the groups were not significantly different. At 
6 months, a further increase in acceptance was observed 
in the MBCT group (mean = 45.3, SD = 13.7) but not in 
RT (mean = 37, SD = 11.8): adjusted mean difference 7 
points (95% CI 3.2–10.7,  p < 0.001).
 Both groups showed similar reductions in disability 
(WSAS) post-treatment and at all time points. By 6 
months, a mean improvement of 5.9 points was observed 
in the MBCT group (mean = 11.8, SD = 10; 95% CI 3.8–
8.6), and a mean of 5.2 points was seen in the RT group 
(mean = 14, SD = 10.2; 95% CI 2.5–7.8). Both groups 
showed a reduction in mean anxiety (HADS-A) and de-
pression (HADS-D) pre- to post-treatment and at 1 and 
6 months (see  Table 3 ). After adjusting for pre-treatment 
scores, there was no significant difference between the 
groups’ scores at either time point. 
 Both groups showed significant increases in mindful-
ness pre- to post-treatment, but it was significantly great-
er in MBCT (mean = 3.8, SD = 0.8) than RT (mean = 3.7, 
SD = 0.8): adjusted mean difference 0.3 (95% CI 0.0–0.60, 
 p = 0.038). At 1 month, increased mindfulness in the RT 
group made the groups equivalent. By 6 months, increas-
es in MBCT (mean = 4.1, SD = 1) and decreases in RT 
(mean = 3.8, SD = 0.9) meant that MBCT had significant-
ly greater mindfulness: adjusted mean difference 0.3 
points (95% CI 0.0–0.6,  p = 0.025).
 Effect of Waiting Period 
 During the waiting period, there was a small reduction 
in tinnitus severity (2.3 points overall), corresponding to 
a standardized effect size of 0.18 (95% CI 0.06–0.31). 
There were small improvements in a number of second-
ary outcomes (VAS, CORE, TCS, HADS-anxiety), but 
none were significantly different between groups (see on-
line suppl. Table 2).
 Practice and Acceptability 
 The number of minutes of practice recorded in the 
participant diaries over the 8-week treatment period was 
high, indicating good adherence. It was substantially dif-
ferent between groups. The mean practice times (in min-
utes) were significantly greater in the MBCT (mean = 
1,315, SD = 548) than in the RT group (mean = 815, 











   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   































p Effect size 
(95% CI)
VAS
Baseline 74.2 (20) 76.3 (20.2)
Pre-treatment 71.4 (18.9) 70.6 (20.3) 2.9 (–7.2 to 12.9) 0.577 0.14 (–0.36 to 0.65)
Post-treatment 59.2 (22.5) 56.6 (25.2) –1.8 (–11.9 to 8.2) 0.721 –0.09 (–0.59 to 0.41)
1-month follow-up 63.4 (23.5) 57.7 (26.9) –4.9 (–15 to 5.1) 0.338 –0.25 (–0.75 to 0.26)
6-month follow-up 65.4 (24.3) 55.1 (29.9) –9.6 (–19.7 to 0.5) 0.063 –0.48 (–0.98 to 0.02)
TFI
Baseline 66.5 (16.7) 63.2 (15.1)
Pre-treatment 62.8 (15.8) 60.6 (16) –1.1 (–8.5 to 6.2) 0.76 –0.07 (–0.54 to 0.39)
Post-treatment 49.2 (19) 42.2 (19.2) –4.8 (–12.2 to 2.5) 0.199  – 0.3 (–0.77 to 0.16)
1-month follow-up 49.7 (21) 42.5 (21.5) –5.1 (–12.5 to 2.2) 0.173 –0.32 (–0.79 to 0.14)
6-month follow-up 49 (21.1) 37.2 (24.1) –9.6 (–17 to –2.3) 0.011 –0.61 (–1.07 to –0.14)
TCS
Baseline 32.2 (11) 30 (10.2)
Pre-treatment 30.1 (12.5) 27.5 (10.9) 0.3 (–3.7 to 4.4) 0.867 0.03 (–0.35 to 0.42)
Post-treatment 23.7 (13.3) 16.5 (11.5) –4.6 (–8.6 to –0.5) 0.029 –0.43 (–0.82 to –0.05)
1-month follow-up 22.7 (14) 16.8 (13.3) –3.2 (–7.3 to 0.9) 0.123 –0.3 (–0.69 to 0.08)
6-month follow-up 22.3 (13.3) 15.1 (12.4) –4.6 (–8.7 to –0.5) 0.028 –0.43 (–0.82 to –0.05)
TFAS
Baseline 50 (11.7) 48.6 (12.3)
Pre-treatment 49.1 (13.8) 47.7 (10.9) 0 (–4.5 to 4.5) 0.992 0 (–0.38 to 0.37)
Post-treatment 45 (13.5) 38.4 (13.3) –5.2 (–9.7 to –0.7) 0.023 –0.44 (–0.81 to –0.06)
1-month follow-up 42.6 (15.4) 38.6 (13.6) –2.6 (–7.1 to 1.8) 0.251 –0.22 (–0.59 to 0.15)
6-month follow-up 43 (14.9) 37.1 (13.2) –4.5 (–9 to 0) 0.05 –0.38 (–0.75 to 0)
TAQ
Baseline 29.4 (11.5) 32 (11.6)
Pre-treatment 31.9 (11.4) 33.3 (10.3) 1.2 (–2.7 to 5.1) 0.542 0.1 (–0.23 to 0.44)
Post-treatment 36.8 (9.8) 42.8 (12.4) 4.7 (0.8 to 8.6) 0.019 0.41 (0.07 to 0.74)
1-month follow-up 37.7 (11.7) 42.6 (13) 3.6 (–0.3 to 7.5) 0.073 0.31 (–0.03 to 0.65)
6-month follow-up 37 (11.8) 45.3 (13.7) 7 (3.1 to 10.9) 0.001 0.6 (0.26 to 0.94)
HADS-A
Baseline 13.1 (3.6) 12.6 (3.3)
Pre-treatment 12.3 (4.1) 12.4 (3.6) –0.7 (–2.2 to 0.9) 0.406 –0.19 (–0.64 to 0.26)
Post-treatment 10.1 (3.9) 9.2 (3.8) –1 (–2.6 to 0.5) 0.196  – 0.3 (–0.74 to 0.15)
1-month follow-up 10 (4.2) 9.7 (3.8) –0.4 (–1.9 to 1.2) 0.647  – 0.1 (–0.55 to 0.34)
6-month follow-up 10.2 (3.7) 9 (3.8) –1.3 (–2.8 to 0.2) 0.098 –0.38 (–0.83 to 0.07)
HADS-D
Baseline 9.3 (4.1) 8.9 (3.6)
Pre-treatment 9 (3.7) 8.4 (3.3) 0.2 (–1.1 to 1.6) 0.757 0.06 (–0.3 to 0.41)
Post-treatment 7.5 (3.8) 6.2 (3.1) –0.6 (–2 to 0.7) 0.35 –0.17 (–0.52 to 0.19)
1-month follow-up 7.6 (4.2) 6.5 (3.3) –0.4 (–1.8 to 0.9) 0.546 –0.11 (–0.46 to 0.25)
6-month follow-up 7.5 (4.2) 5.6 (3.6) –1.3 (–2.6 to 0.1) 0.069 –0.33 (–0.69 to 0.02)
WSAS
Baseline 20 (10.1) 18.2 (9.5)
Pre-treatment 19.2 (10.2) 17.7 (9.5) –0.3 (–3.3 to 2.8) 0.858 –0.03 (–0.34 to 0.28)
Post-treatment 15.4 (9.8) 12.6 (8.5) –1.2 (–4.3 to 1.8) 0.423 –0.13 (–0.44 to 0.18)
1-month follow-up 13.7 (9.7) 13.3 (9.5) 1.2 (–1.9 to 4.2) 0.459 0.12 (–0.19 to 0.43)
6-month follow-up 14 (10.2) 11.8 (10) –0.7 (–3.8 to 2.3) 0.647 –0.07 (–0.39 to 0.24)
MAAS
Baseline 3.5 (0.9) 3.6 (0.9)
Pre-treatment 3.6 (0.9) 3.5 (0.9) 0.2 (–0.1 to 0.5) 0.118 0.27 (–0.07 to 0.6)
Post-treatment 3.7 (0.8) 3.9 (0.8) 0.3 (0 to 0.6) 0.038 0.35 (0.02 to 0.69)
1-month follow-up 3.9 (1) 4 (0.9) 0.2 (–0.1 to 0.5) 0.302 0.18 (–0.16 to 0.51)
6-month follow-up 3.8 (0.9) 4.1 (1) 0.3 (0 to 0.6) 0.025 0.38 (0.05 to 0.72)
 RT, relaxation therapy; MBCT, mindfulness-based cognitive therapy; VAS, Visual Analogue Scale (tinnitus loudness); TCS, Tinnitus Catastrophizing 
Scale; T-FAS, Tinnitus Fear Avoidance Scale; TAQ, Tinnitus Acceptance Questionnaire; HADS-A, Hospital Anxiety and Depression Scale – Anxiety; HADS-
D, Hospital Anxiety and Depression Scale – Depression; WSAS, Work and Social Adjustment Scale (functioning); MAAS, Mindful Attention Awareness 
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ment methodology. Within each group, no significant 
correlation was found between reduction in tinnitus se-
verity and practice time during treatment. Both groups 
rated both treatments equivalently highly on scales of 
“usefulness” (mean = 8.2, SD = 1.5) and “relevance” 
(mean = 8.4, SD = 1.5). Both groups attended the major-
ity of treatment sessions (mean = 6.9, SD = 1.9), demon-
strating good adherence and engagement ( Table 1 ). 
 Adverse Events and Non-Responders 
 We recorded 2 adverse events (1 in each group). One 
MBCT participant reported significant depression at 6 
months, and 1 RT participant reported significant anxiety 
at the 6-month follow-up. Following discussion with each 
individual, neither event was considered to be related to 
the intervention; the changes were associated with chang-
ing life circumstances. To assess for negative side effects 
of psychotherapy, data were analysed for significant de-
terioration or lack of significant change on the primary 
outcomes. A total of 3 participants in each group showed 
significant deterioration (see online suppl. Table 3).
 Discussion 
 This study clearly shows that MBCT is more effective 
in reducing tinnitus severity than both a waiting period 
and an active treatment of equal intensity (RT). After re-
ceiving 8 weeks of treatment, patients in the MBCT group 
reported significantly less severe tinnitus, with a moder-
ate effect size (standardized mean difference = 0.59). Both 
MBCT and RT were additionally associated with reduc-
tions in self-reported tinnitus loudness, psychological 
distress, depression and anxiety, and impairments in 
functioning and tinnitus impact, which was also signifi-
cantly lower in MBCT after 6 months. Recent meta-anal-
yses of therapy for tinnitus report outcomes that compare 
favourably with ours  [3, 4, 32] , also reporting moderate 
effects on tinnitus severity and small effects on psycho-
logical distress when compared to active controls. Unlike 
our study, these meta-analyses do not report any reduc-
tion in subjective tinnitus loudness.
 Reliable change in tinnitus distress was seen in a large 
proportion of the MBCT group (59% post-treatment in-
creasing to 62% at 6 months), with an NNT of 6.9. This 
was not statistically different between groups, and is 
probably due to insufficient power for this particular 
analysis, but it demonstrates the clinically important ef-
fect of MBCT for tinnitus. Benefits were found regardless 
of initial tinnitus severity, duration, and associated hear-
ing loss, within a group of patients with clinical levels of 
psychological distress. This supports our hypothesis that 
MBCT is a successful treatment for distressed tinnitus pa-
tients who are likely to present to clinical services. How-
ever, 48 (27%) of participants were excluded due to phys-
ical and mental health comorbidities, which limits gener-
alizability somewhat. Further research could explore 
whether MBCT might also apply in more complex cases 
(our own clinical experience suggests that this is the case). 
 We note that there was a difference between measures 
of tinnitus severity, with differences on the TQ apparent 
at the end of treatment, but differences in the TFI emerg-
ing only at 6 months. This probably reflects less respon-
siveness to change of the TFI in research samples  [27] , 
although both show that MBCT is superior to RT in re-
ducing tinnitus severity.
 As expected, MBCT generated greater reductions in 
negative cognition and avoidance behaviour and greater 
increases in tinnitus acceptance and mindfulness than 
RT. Such changes emerged more quickly in MBCT and 
were then sustained and even increased over 6 months. 
Such changes are clinically relevant as negative cognition, 
avoidance, and acceptance correlate with tinnitus sever-
ity, distress, and handicap  [16–18] . Interestingly, the RT 
group also showed increased mindfulness, and we postu-
late that the process of increased attention to physical ten-
sion and applied relaxation skills are in part captured by 
the MAAS scale. 
 Contrary to our hypothesis, both treatments led to a 
significant reduction in subjective tinnitus loudness on 
the VAS. Reduction in self-reported tinnitus loudness is 
often not found in tinnitus intervention studies, and our 
observation may relate to the phrasing of the question. 
 A common pattern of change across measures found 
group differences post-treatment that disappeared at 1 
month but re-emerged at 6 months. This pattern suggests 
that MBCT may lead to faster improvements that are stable 
and then grow in the longer term, however, whilst RT leads 
to slower changes that continue for the following month. 
However, in the longer term, whilst MBCT is associated 
with growing benefits, the gains from RT plateau or dete-
riorate. This supports an earlier study which found that 
benefits of psycho-education are enhanced by MBCT but 
not by RT  [12] . It indicates that MBCT can lead to more 
lasting improvement than RT. This may be related to the 
greater cognitive and behavioural changes seen in MBCT.
 The low attrition rate (11% in RT and 5% in MBCT) 
demonstrates the acceptability of this approach. It com-
pares favourably with attrition from CBT  [5] , and is re-











   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
























“usefulness.” Participants receiving MBCT reported 
practising for longer periods at home, despite both groups 
being given similar practice demands and audio guides to 
support this. We posit that MBCT practices are more en-
gaging, and that this could be an important part of the 
treatment effect. Within each group, however, the dura-
tion of practice was not associated with outcome. 
 Very few participants showed non-response or dete-
rioration, which is encouraging in terms of generalizabil-
ity, but the low numbers mean that analyses could not be 
conducted to identify whether specific patient character-
istics may contraindicate this therapy. This is a limitation 
of randomized controlled trials which prevents the devel-
opment of clear guidelines for treating individual pa-
tients, particularly those with complex presentations 
 [33] . Future studies should explore associations with pa-
tient characteristics and response to MBCT, particularly 
in the longer term. Future research could also consider 
the use of systematic patient feedback throughout treat-
ment, particularly using specific measures that can assess 
deterioration or non-response, a method that can also 
lead to improved recovery rates  [34] .
 The use of the standardized 8-week MBCT protocol 
has not been studied in this population before. Although 
previous studies have found benefits of mindfulness in 
tinnitus, there are only 2 controlled trials  [12, 13] , and 
both reported on small sample sizes and non-standard-
ized treatment protocols. To our knowledge, no previous 
randomized controlled trial of this scale has properly in-
vestigated a standardized and replicable MBCT interven-
tion in chronic tinnitus with a sample size that offers ad-
equate statistical power. 
 Strengths of our study are the inclusion of participants 
who would commonly be seen in tinnitus clinics, because 
although some complex cases were excluded, all partici-
pants reported clinical levels of psychological distress, 
and many had co-morbidities such as hearing loss, hyper-
acusis, balance problems, Ménière’s disease, and mi-
graine. This demonstrates that MBCT is relevant to pa-
tients with varied audiovestibular presentations. Other 
strengths are the sample size – the largest to date in a 
trial of MBCT in this population – and low attrition rates. 
The comparison of MBCT to a credible treatment control 
that required similar levels of participant engagement in 
skills practice, and outwardly similar processes of being 
relatively quiet and still with tinnitus, is compelling, sug-
gesting that group differences are likely to be due to spe-
cific aspects of MBCT. Through comparison with RT we 
feel that active ingredients of MBCT go beyond simple 
exposure (i.e., minimizing avoidance by sitting quietly 
with tinnitus), and appears to target specific domains of 
catastrophic thinking, fear avoidance, and acceptance, 
with associated changes in mindfulness. 
 There are a number of limitations to the study. MBCT 
is a complex, multicomponent, group-based intervention, 
and future studies should attempt to delineate the active 
elements of treatment, preferably using a standard, repli-
cable protocol. We are also investigating processes of 
change with mediation analyses and using qualitative 
analysis to explore how therapeutic alliance, group dy-
namic, and other aspects of therapy may affect experienc-
es and outcomes. The delivery of treatment within a spe-
cialist outpatient clinic and via clinical psychologists could 
limit generalizability of findings. With few psychology 
services available in audiology and increasing delivery of 
mindfulness via non-psychotherapeutically trained pro-
fessionals  [35] , it is important that future studies explore 
MBCT delivered in general audiology settings through 
other health care professionals, preferably using standard-
ized intervention protocols such as the one described here.
 We did not control for all potential confounding fac-
tors that could affect tinnitus symptoms, such as the use 
of hearing aids, masking devices, or psychotropic medi-
cation. We did, however, request that participants inform 
us of any changes to their medical care throughout the 
duration of the trial, and none were reported. Another 
limitation is the lack of an objective audiological measure 
of tinnitus loudness and reliance on self-report measures. 
The MBCT group received supporting literature, but the 
RT group did not. It is possible that this additional input 
could have added to the positive effects of MBCT, par-
ticularly considering the impact that psycho-education 
has on tinnitus  [12] . However, we note that this difference 
reflects the underlying differences in the interventions 
themselves, as MBCT recommends supporting literature 
 [14] and RT does not  [22] . 
 Our study offers clear evidence that MBCT is an effec-
tive treatment for tinnitus, using a standard and replica-
ble approach that could be adopted widely for tinnitus 
management in a field where clinical interventions are 
limited  [5] . Mindfulness is already being explored by the 
audiology community  [20] . Our study adds more support 
to the use of MBCT as a further route for patient benefit. 
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